0001735276-19-000031.txt : 20190301 0001735276-19-000031.hdr.sgml : 20190301 20190301180940 ACCESSION NUMBER: 0001735276-19-000031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190228 FILED AS OF DATE: 20190301 DATE AS OF CHANGE: 20190301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KEATING LAURIE CENTRAL INDEX KEY: 0001620743 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36407 FILM NUMBER: 19651046 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2019-02-28 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001620743 KEATING LAURIE 300 THIRD STREET CAMBRIDGE MA 02142 0 1 0 0 SVP, GC & Secretary Stock Option (right to buy) 85.0 2019-02-28 4 A 0 25000 0.0 A 2029-02-27 Common Stock 25000 25000 D Represents the time-vested portion of the reporting person's Annual Stock Option Award for 2018. The reporting person also received 12,500 performance stock units that will vest upon the achievement of three specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests. The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Laurie Keating 2019-03-01